Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 May;95(5):2150–2160. doi: 10.1172/JCI117904

The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance.

D C Zeldin 1, J D Plitman 1, J Kobayashi 1, R F Miller 1, J R Snapper 1, J R Falck 1, J L Szarek 1, R M Philpot 1, J H Capdevila 1
PMCID: PMC295817  PMID: 7738183

Abstract

Cytochrome P450 metabolizes arachidonic acid to several unique and biologically active compounds in rabbit liver and kidney. Microsomal fractions prepared from rabbit lung homogenates metabolized arachidonic acid through cytochrome P450 pathways, yielding cis-epoxyeicosatrienoic acids (EETs) and their hydration products, vic-dihydroxyeicosatrienoic acids, mid-chain cis-trans conjugated dienols, and 19- and 20-hydroxyeicosatetraenoic acids. Inhibition studies using polyclonal antibodies prepared against purified CYP2B4 demonstrated 100% inhibition of arachidonic acid epoxide formation. Purified CYP2B4, reconstituted in the presence of NADPH-cytochrome P450 reductase and cytochrome b5, metabolized arachidonic acid, producing primarily EETs. EETs were detected in lung homogenate using gas chromatography/mass spectroscopy, providing evidence for the in vivo pulmonary cytochrome P450 epoxidation of arachidonic acid. Chiral analysis of these lung EETs demonstrated a preference for the 14(R),15(S)-, 11(S),12(R)-, and 8(S),9(R)-EET enantiomers. Both EETs and vic-dihydroxyeicosatrienoic acids were detected in bronchoalveolar lavage fluid. At micromolar concentrations, methylated 5,6-EET and 8,9-EET significantly relaxed histamine-contracted guinea pig hilar bronchi in vitro. In contrast, 20-hydroxyeicosatetraenoic acid caused contraction to near maximal tension. We conclude that CYP2B4, an abundant rabbit lung cytochrome P450 enzyme, is the primary constitutive pulmonary arachidonic acid epoxygenase and that these locally produced, biologically active eicosanoids may be involved in maintaining homeostasis within the lung.

Full text

PDF
2150

Images in this article

2153Image
on p.2153

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  2. Capdevila J. H., Dishman E., Karara A., Falck J. R. Cytochrome P450 arachidonic acid epoxygenase: stereochemical characterization of epoxyeicosatrienoic acids. Methods Enzymol. 1991;206:441–453. doi: 10.1016/0076-6879(91)06113-h. [DOI] [PubMed] [Google Scholar]
  3. Capdevila J. H., Falck J. R., Dishman E., Karara A. Cytochrome P-450 arachidonate oxygenase. Methods Enzymol. 1990;187:385–394. doi: 10.1016/0076-6879(90)87045-5. [DOI] [PubMed] [Google Scholar]
  4. Capdevila J. H., Falck J. R., Estabrook R. W. Cytochrome P450 and the arachidonate cascade. FASEB J. 1992 Jan 6;6(2):731–736. doi: 10.1096/fasebj.6.2.1537463. [DOI] [PubMed] [Google Scholar]
  5. Capdevila J. H., Karara A., Waxman D. J., Martin M. V., Falck J. R., Guenguerich F. P. Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J Biol Chem. 1990 Jul 5;265(19):10865–10871. [PubMed] [Google Scholar]
  6. Capdevila J. H., Wei S., Yan J., Karara A., Jacobson H. R., Falck J. R., Guengerich F. P., DuBois R. N. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem. 1992 Oct 25;267(30):21720–21726. [PubMed] [Google Scholar]
  7. Capdevila J., Chacos N., Falck J. R., Manna S., Negro-Vilar A., Ojeda S. R. Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence. Endocrinology. 1983 Jul;113(1):421–423. doi: 10.1210/endo-113-1-421. [DOI] [PubMed] [Google Scholar]
  8. Capdevila J., Chacos N., Werringloer J., Prough R. A., Estabrook R. W. Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5362–5366. doi: 10.1073/pnas.78.9.5362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Capdevila J., Kim Y. R., Martin-Wixtrom C., Falck J. R., Manna S., Estabrook R. W. Influence of a fibric acid type of hypolipidemic agent on the oxidative metabolism of arachidonic acid by liver microsomal cytochrome P-450. Arch Biochem Biophys. 1985 Nov 15;243(1):8–19. doi: 10.1016/0003-9861(85)90768-4. [DOI] [PubMed] [Google Scholar]
  10. Capdevila J., Pramanik B., Napoli J. L., Manna S., Falck J. R. Arachidonic acid epoxidation: epoxyeicosatrienoic acids are endogenous constituents of rat liver. Arch Biochem Biophys. 1984 Jun;231(2):511–517. doi: 10.1016/0003-9861(84)90415-6. [DOI] [PubMed] [Google Scholar]
  11. Carroll M. A., Garcia M. P., Falck J. R., McGiff J. C. 5,6-epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat. Circ Res. 1990 Nov;67(5):1082–1088. doi: 10.1161/01.res.67.5.1082. [DOI] [PubMed] [Google Scholar]
  12. Catella F., Lawson J. A., Fitzgerald D. J., FitzGerald G. A. Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5893–5897. doi: 10.1073/pnas.87.15.5893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chacos N., Capdevila J., Falck J. R., Manna S., Martin-Wixtrom C., Gill S. S., Hammock B. D., Estabrook R. W. The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. Arch Biochem Biophys. 1983 Jun;223(2):639–648. doi: 10.1016/0003-9861(83)90628-8. [DOI] [PubMed] [Google Scholar]
  14. Chacos N., Falck J. R., Wixtrom C., Capdevila J. Novel epoxides formed during the liver cytochrome P-450 oxidation of arachidonic acid. Biochem Biophys Res Commun. 1982 Feb 11;104(3):916–922. doi: 10.1016/0006-291x(82)91336-5. [DOI] [PubMed] [Google Scholar]
  15. Dees J. H., Coe L. D., Yasukochi Y., Masters B. S. Immunofluorescence of NADPH-cytochrome c (P-450) reductase in rat and minipig tissues injected with phenobarbital. Science. 1980 Jun 27;208(4451):1473–1475. doi: 10.1126/science.6770464. [DOI] [PubMed] [Google Scholar]
  16. Domin B. A., Devereux T. R., Philpot R. M. The cytochrome P-450 monooxygenase system of rabbit lung enzyme components, activities, and induction in the nonciliated bronchiolar epithelial (Clara) cell, alveolar type II cell, and alveolar macrophage. Mol Pharmacol. 1986 Sep;30(3):296–303. [PubMed] [Google Scholar]
  17. Falck J. R., Manna S., Moltz J., Chacos N., Capdevila J. Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets. Biochem Biophys Res Commun. 1983 Jul 29;114(2):743–749. doi: 10.1016/0006-291x(83)90843-4. [DOI] [PubMed] [Google Scholar]
  18. Falck J. R., Yadagiri P., Capdevila J. Synthesis of epoxyeicosatrienoic acids and heteroatom analogs. Methods Enzymol. 1990;187:357–364. doi: 10.1016/0076-6879(90)87042-2. [DOI] [PubMed] [Google Scholar]
  19. Fitzpatrick F. A., Ennis M. D., Baze M. E., Wynalda M. A., McGee J. E., Liggett W. F. Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry. J Biol Chem. 1986 Nov 15;261(32):15334–15338. [PubMed] [Google Scholar]
  20. Fitzpatrick F. A., Murphy R. C. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. Pharmacol Rev. 1988 Dec;40(4):229–241. [PubMed] [Google Scholar]
  21. Gasser R., Negishi M., Philpot R. M. Primary structures of multiple forms of cytochrome P-450 isozyme 2 derived from rabbit pulmonary and hepatic cDNAs. Mol Pharmacol. 1988 Jan;33(1):22–30. [PubMed] [Google Scholar]
  22. Gasser R., Philpot R. M. Primary structures of cytochrome P-450 isozyme 5 from rabbit and rat and regulation of species-dependent expression and induction in lung and liver: identification of cytochrome P-450 gene subfamily IVB. Mol Pharmacol. 1989 May;35(5):617–625. [PubMed] [Google Scholar]
  23. Gast K., Zirwer D., Ladhoff A. M., Schreiber J., Koelsch R., Kretschmer K., Lasch J. Auto-oxidation-induced fusion of lipid vesicles. Biochim Biophys Acta. 1982 Mar 23;686(1):99–109. doi: 10.1016/0005-2736(82)90155-9. [DOI] [PubMed] [Google Scholar]
  24. Gebremedhin D., Ma Y. H., Falck J. R., Roman R. J., VanRollins M., Harder D. R. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol. 1992 Aug;263(2 Pt 2):H519–H525. doi: 10.1152/ajpheart.1992.263.2.H519. [DOI] [PubMed] [Google Scholar]
  25. Guengerich F. P., Dannan G. A., Wright S. T., Martin M. V., Kaminsky L. S. Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry. 1982 Nov 9;21(23):6019–6030. doi: 10.1021/bi00266a045. [DOI] [PubMed] [Google Scholar]
  26. Hammonds T. D., Blair I. A., Falck J. R., Capdevila J. H. Resolution of epoxyeicosatrienoate enantiomers by chiral phase chromatography. Anal Biochem. 1989 Nov 1;182(2):300–303. doi: 10.1016/0003-2697(89)90598-8. [DOI] [PubMed] [Google Scholar]
  27. Harris R. C., Homma T., Jacobson H. R., Capdevila J. Epoxyeicosatrienoic acids activate Na+/H+ exchange and are mitogenic in cultured rat glomerular mesangial cells. J Cell Physiol. 1990 Sep;144(3):429–437. doi: 10.1002/jcp.1041440310. [DOI] [PubMed] [Google Scholar]
  28. Hassett C., Omiecinski C. J. Sequence and gene expression of rabbit cytochrome P450 IIC16: comparison to highly related family members. Nucleic Acids Res. 1990 Mar 25;18(6):1429–1434. doi: 10.1093/nar/18.6.1429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Karara A., Dishman E., Blair I., Falck J. R., Capdevila J. H. Endogenous epoxyeicosatrienoic acids. Cytochrome P-450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase. J Biol Chem. 1989 Nov 25;264(33):19822–19827. [PubMed] [Google Scholar]
  30. Karara A., Dishman E., Falck J. R., Capdevila J. H. Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties. J Biol Chem. 1991 Apr 25;266(12):7561–7569. [PubMed] [Google Scholar]
  31. Karara A., Wei S., Spady D., Swift L., Capdevila J. H., Falck J. R. Arachidonic acid epoxygenase: structural characterization and quantification of epoxyeicosatrienoates in plasma. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1320–1325. doi: 10.1016/0006-291x(92)91877-s. [DOI] [PubMed] [Google Scholar]
  32. Katoh T., Takahashi K., Capdevila J., Karara A., Falck J. R., Jacobson H. R., Badr K. F. Glomerular stereospecific synthesis and hemodynamic actions of 8,9-epoxyeicosatrienoic acid in rat kidney. Am J Physiol. 1991 Oct;261(4 Pt 2):F578–F586. doi: 10.1152/ajprenal.1991.261.4.F578. [DOI] [PubMed] [Google Scholar]
  33. Knickle L. C., Bend J. R. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids. Mol Pharmacol. 1994 Jun;45(6):1273–1280. [PubMed] [Google Scholar]
  34. Laethem R. M., Laethem C. L., Koop D. R. Purification and properties of a cytochrome P450 arachidonic acid epoxygenase from rabbit renal cortex. J Biol Chem. 1992 Mar 15;267(8):5552–5559. [PubMed] [Google Scholar]
  35. Malcolm K. C., Fitzpatrick F. A. Epoxyeicosatrienoic acids inhibit Ca2+ entry into platelets stimulated by thapsigargin and thrombin. J Biol Chem. 1992 Oct 5;267(28):19854–19858. [PubMed] [Google Scholar]
  36. Masferrer J. L., Murphy R. C., Pagano P. J., Dunn M. W., Laniado-Schwartzman M. Ocular effects of a novel cytochrome P-450-dependent arachidonic acid metabolite. Invest Ophthalmol Vis Sci. 1989 Mar;30(3):454–460. [PubMed] [Google Scholar]
  37. Masferrer J. L., Rimarachin J. A., Gerritsen M. E., Falck J. R., Yadagiri P., Dunn M. W., Laniado-Schwartzman M. 12(R)-hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the cornea. Exp Eye Res. 1991 Apr;52(4):417–424. doi: 10.1016/0014-4835(91)90037-f. [DOI] [PubMed] [Google Scholar]
  38. Masters B. S., Okita R. T., Muerhoff A. S., Leithauser M. T., Gee A., Winquist S., Roerig D. L., Clark J. E., Murphy R. C., Ortiz de Montellano P. Pulmonary P-450-mediated eicosanoid metabolism and regulation in the pregnant rabbit. Adv Prostaglandin Thromboxane Leukot Res. 1989;19:335–338. [PubMed] [Google Scholar]
  39. McGiff J. C. Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol. 1991;31:339–369. doi: 10.1146/annurev.pa.31.040191.002011. [DOI] [PubMed] [Google Scholar]
  40. Miller M. A., Hales C. A. Role of cytochrome P-450 in alveolar hypoxic pulmonary vasoconstriction in dogs. J Clin Invest. 1979 Aug;64(2):666–673. doi: 10.1172/JCI109507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Morrison A. R., Pascoe N. Metabolism of arachidonate through NADPH-dependent oxygenase of renal cortex. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7375–7378. doi: 10.1073/pnas.78.12.7375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Muccitelli R. M., Tucker S. S., Hay D. W., Torphy T. J., Wasserman M. A. Is the guinea pig trachea a good in vitro model of human large and central airways? Comparison on leukotriene-, methacholine-, histamine- and antigen-induced contractions. J Pharmacol Exp Ther. 1987 Nov;243(2):467–473. [PubMed] [Google Scholar]
  43. Murphy R. C., Falck J. R., Lumin S., Yadagiri P., Zirrolli J. A., Balazy M., Masferrer J. L., Abraham N. G., Schwartzman M. L. 12(R)-hydroxyeicosatrienoic acid: a vasodilator cytochrome P-450-dependent arachidonate metabolite from the bovine corneal epithelium. J Biol Chem. 1988 Nov 15;263(32):17197–17202. [PubMed] [Google Scholar]
  44. Needleman P., Turk J., Jakschik B. A., Morrison A. R., Lefkowith J. B. Arachidonic acid metabolism. Annu Rev Biochem. 1986;55:69–102. doi: 10.1146/annurev.bi.55.070186.000441. [DOI] [PubMed] [Google Scholar]
  45. O'Donnell S. R., Wanstall J. C., Kay C. S., Zeng X. P. Tissue selectivity and spasmogen selectivity of relaxant drugs in airway and pulmonary vascular smooth muscle contracted by PGF2 alpha or endothelin. Br J Pharmacol. 1991 Feb;102(2):311–316. doi: 10.1111/j.1476-5381.1991.tb12171.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Okino S. T., Quattrochi L. C., Barnes H. J., Osanto S., Griffin K. J., Johnson E. F., Tukey R. H. Cloning and characterization of cDNAs encoding 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible rabbit mRNAs for cytochrome P-450 isozymes 4 and 6. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5310–5314. doi: 10.1073/pnas.82.16.5310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Okita R. T., Soberman R. J., Bergholte J. M., Masters B. S., Hayes R., Murphy R. C. omega-Hydroxylation of 15-hydroxyeicosatetraenoic acid by lung microsomes from pregnant rabbits. Mol Pharmacol. 1987 Nov;32(5):706–709. [PubMed] [Google Scholar]
  48. Oliw E. H., Guengerich F. P., Oates J. A. Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates. J Biol Chem. 1982 Apr 10;257(7):3771–3781. [PubMed] [Google Scholar]
  49. Oliw E. H. Isolation and chemical conversion of two novel prostaglandin endoperoxides: 5(6)-epoxy-PGG1 and 5(6)-epoxy-PGH1. FEBS Lett. 1984 Jul 9;172(2):279–283. doi: 10.1016/0014-5793(84)81141-2. [DOI] [PubMed] [Google Scholar]
  50. Oliw E. H., Lawson J. A., Brash A. R., Oates J. A. Arachidonic acid metabolism in rabbit renal cortex. Formation of two novel dihydroxyeicosatrienoic acids. J Biol Chem. 1981 Oct 10;256(19):9924–9931. [PubMed] [Google Scholar]
  51. Oliw E. H., Moldéus P. Metabolism of arachidonic acid by isolated rat hepatocytes, renal cells and by some rabbit tissues. Detection of vicinal diols by mass fragmentography. Biochim Biophys Acta. 1982 Oct 11;721(2):135–143. doi: 10.1016/0167-4889(82)90061-1. [DOI] [PubMed] [Google Scholar]
  52. Parandoosh Z., Fujita V. S., Coon M. J., Philpot R. M. Cytochrome P-450 isozymes 2 and 5 in rabbit lung and liver. Comparisons of structure and inducibility. Drug Metab Dispos. 1987 Jan-Feb;15(1):59–67. [PubMed] [Google Scholar]
  53. Philpot R. M., Smith B. R. Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics. Environ Health Perspect. 1984 Apr;55:359–367. doi: 10.1289/ehp.8455359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Proctor K. G., Falck J. R., Capdevila J. Intestinal vasodilation by epoxyeicosatrienoic acids: arachidonic acid metabolites produced by a cytochrome P450 monooxygenase. Circ Res. 1987 Jan;60(1):50–59. doi: 10.1161/01.res.60.1.50. [DOI] [PubMed] [Google Scholar]
  55. Schwartzman M. L., Balazy M., Masferrer J., Abraham N. G., McGiff J. C., Murphy R. C. 12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8125–8129. doi: 10.1073/pnas.84.22.8125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Serabjit-Singh C. J., Nishio S. J., Philpot R. M., Plopper C. G. The distribution of cytochrome P-450 monooxygenase in cells of the rabbit lung: an ultrastructural immunocytochemical characterization. Mol Pharmacol. 1988 Mar;33(3):279–289. [PubMed] [Google Scholar]
  57. Serabjit-Singh C. J., Wolf C. R., Philpot R. M. The rabbit pulmonary monooxygenase system. Immunochemical and biochemical characterization of enzyme components. J Biol Chem. 1979 Oct 10;254(19):9901–9907. [PubMed] [Google Scholar]
  58. Sevanian A., Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr. 1985;5:365–390. doi: 10.1146/annurev.nu.05.070185.002053. [DOI] [PubMed] [Google Scholar]
  59. Sevanian A., Mead J. F., Stein R. A. Epoxides as products of lipid autoxidation in rat lungs. Lipids. 1979 Jul;14(7):634–643. doi: 10.1007/BF02533449. [DOI] [PubMed] [Google Scholar]
  60. Sylvester J. T., McGowan C. The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vasoconstriction. Circ Res. 1978 Sep;43(3):429–437. doi: 10.1161/01.res.43.3.429. [DOI] [PubMed] [Google Scholar]
  61. Szarek J. L., Schmidt N. L. Hydrogen peroxide-induced potentiation of contractile responses in isolated rat airways. Am J Physiol. 1990 Apr;258(4 Pt 1):L232–L237. doi: 10.1152/ajplung.1990.258.4.L232. [DOI] [PubMed] [Google Scholar]
  62. Tindberg N., Ingelman-Sundberg M. Cytochrome P-450 and oxygen toxicity. Oxygen-dependent induction of ethanol-inducible cytochrome P-450 (IIE1) in rat liver and lung. Biochemistry. 1989 May 16;28(10):4499–4504. doi: 10.1021/bi00436a056. [DOI] [PubMed] [Google Scholar]
  63. Vanderslice R. R., Domin B. A., Carver G. T., Philpot R. M. Species-dependent expression and induction of homologues of rabbit cytochrome P-450 isozyme 5 in liver and lung. Mol Pharmacol. 1987 Apr;31(4):320–325. [PubMed] [Google Scholar]
  64. Waechter F., Bentley P., Bieri F., Muakkassah-Kelly S., Stäubli W., Villermain M. Organ distribution of epoxide hydrolases in cytosolic and microsomal fractions of normal and nafenopin-treated male DBA/2 mice. Biochem Pharmacol. 1988 Oct 15;37(20):3897–3903. doi: 10.1016/0006-2952(88)90071-8. [DOI] [PubMed] [Google Scholar]
  65. Yasukochi Y., Masters B. S. Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography. J Biol Chem. 1976 Sep 10;251(17):5337–5344. [PubMed] [Google Scholar]
  66. Zeldin D. C., Kobayashi J., Falck J. R., Winder B. S., Hammock B. D., Snapper J. R., Capdevila J. H. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem. 1993 Mar 25;268(9):6402–6407. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES